SCHEMBL23924161

SCHEMBL23924161

C=C(CCCCCCCCCC)CCC(C)CCCC

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACE2 Q9BYF1 1/20 0.44
DNM1 Q05193 2/20 0.38
LMNA P02545 2/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
FAAH O00519 1/20 0.37
MAPK1 P28482 1/20 0.37
CES2 O00748 3/20 0.37
CES1 P23141 3/20 0.37
MAPT P10636 1/20 0.37
FFAR4 Q5NUL3 1/20 0.36
FFAR1 O14842 1/20 0.36
PRKD3 O94806 1/20 0.36
PRKCG P05129 1/20 0.36
PRKCB P05771 1/20 0.36
PRKCA P17252 1/20 0.36
PRKCH P24723 1/20 0.36
PRKCI P41743 1/20 0.36
PRKCE Q02156 1/20 0.36
PRKCQ Q04759 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7744131 1.00 ACE2 (0.44) ACE2DNM1LMNAMEN1KMT2A
SCHEMBL23924338 0.94 ACE2 (0.41) ACE2LMNAMEN1KMT2AFAAH
SCHEMBL7738197 0.94 ACE2 (0.46) ACE2LMNAMEN1KMT2AFAAH
SCHEMBL23923682 0.94 ACE2 (0.50) ACE2DNM1LMNAMEN1KMT2A
SCHEMBL7743504 0.92 ACE2 (0.40) ACE2LMNAMEN1KMT2AFAAH
SCHEMBL31521496 0.92 MAPT (0.39) ACE2DNM1LMNAMAPK1CES2
SCHEMBL7744113 0.92 ACE2 (0.42) ACE2DNM1LMNAMEN1KMT2A
SCHEMBL7738232 0.88 ACE2 (0.44) ACE2LMNAMEN1KMT2AFAAH
SCHEMBL24681420 0.88 ALDH1A1 (0.39) LMNAMEN1KMT2AFAAHMAPK1
SCHEMBL7746021 0.88 ALDH1A1 (0.39) LMNAMEN1KMT2AFAAHMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11174205-B2 C20 2-substituted alpha olefins produced by dimerization of branched C10 olefins CHEVRON PHILLIPS CHEMICAL COMPANY, LP (US) 2021-11-16 US claimed
US-20210323892-A1 C20 2-Substituted Alpha Olefins Produced By Dimerization Of Branched C10 Olefins CHEVRON PHILLIPS CHEMICAL COMPANY LP 2021-10-21 US claimed
WO-2025264609-A1 C20 TRISUBSTITUTED OLEFINS PRODUCED BY ACIDIC CATALYZED REACTION OF C20 2-SUBSTITUTED ALPHA OLEFINS CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2025-12-26 WO disclosed
US-20250382242-A1 C20 TRISUBSTITUTED OLEFINS PRODUCED BY ACIDIC CATALYZED REACTION OF C20 2-SUBSTITUTED ALPHA OLEFINS CHEVRON PHILLIPS CHEMICAL CO LP (US) 2025-12-18 US disclosed
US-11174205-B2 C20 2-substituted alpha olefins produced by dimerization of branched C10 olefins CHEVRON PHILLIPS CHEMICAL COMPANY, LP (US) 2021-11-16 US disclosed
US-20210323892-A1 C20 2-Substituted Alpha Olefins Produced By Dimerization Of Branched C10 Olefins CHEVRON PHILLIPS CHEMICAL COMPANY LP 2021-10-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250382242-A1 C20 TRISUBSTITUTED OLEFINS PRODUCED BY ACIDIC CATALYZED REACTION OF C20 2-SUBSTITUTED ALPHA OLEFINS COASY, MOGAT2, HSD17B12 ACE2 2252/4885DNM1 962/4885LMNA 4311/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.